Trials
1 active
7 in total · 4 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Impaired Hepatic Function
- Main trialPhase 1
- “This clinical research trial is testing the investigational medicinal product (IMP) petrelintide that is being developed for body weight reduction in people living with obesity or overweight who have comorbidities. The aim of this clinical research trial is to investigate whether the pharmacokinetics (PK) of petrelintide will be different in people with hepatic impairment (HI) compared to people with normal hepatic function.”In the company’s words, NCT07682818 on ClinicalTrials.gov
- Other names
- ZP8396
Other drugs for Impaired Hepatic Function
- Custodiol-NDr. F. Köhler Chemie GmbH · Phase 3
- TYNADOTESinew Pharma Inc. · Phase 2
- LYG-LIV0001LyGenesis, Inc. · Phase 2
- NTZGenfit · Phase 2
- EGEN-5784eGenesis, INC · Phase 1/2
- TAK-242Yaqrit Ltd · Phase 2
Coming up1
- 12 Apr 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 12 Apr 2027 | Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function | |
| Phase 2Completed | 30 Sep 2025 | Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities | |
| Phase 2Completed | 13 Aug 2026 | Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) | |
| Phase 1Completed | 12 Jan 2023 | A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants | |
| Phase 1Completed | 13 Jun 2024 | A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants | |
| Phase 1Completed | 25 Nov 2025 | Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function | |
| Phase 1Completed | 31 Mar 2026 | Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026